Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Trastornos del Movimiento
FILTRAR POR:
Por tema
5195 ARTÍCULOS , VIENDO DEL 1366 AL 1380
Damage in Mitochondrial DNA Associated with Parkinson's Disease
Martín-Jiménez R, Lurette O, Hebert-Chatelain E.
DNA Cell Biol. 2020 Aug;39(8):1421-1430. doi: 10.1089/dna.2020.5398. Epub 2020 May 12.
Clinical characterization of patients with leucine-rich repeat kinase 2 genetic variants in Japan
Li Y, Ikeda A, Yoshino H, Oyama G, Kitani M, Daida K, Hayashida A, Ogaki K, Yoshida K, Kimura T, Nakayama Y, Ito H, Sugeno N, Aoki M, Miyajima H, Kimura K, Ueda N, Watanabe M, Urabe T, Takanashi M, Funayama M, Nishioka K, Hattori N.
J Hum Genet. 2020 Sep;65(9):771-781. doi: 10.1038/s10038-020-0772-4. Epub 2020 May 13.
Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson's Disease
Schweitzer JS, Song B, Herrington TM, Park TY, Lee N, Ko S, Jeon J, Cha Y, Kim K, Li Q, Henchcliffe C, Kaplitt M, Neff C, Rapalino O, Seo H, Lee IH, Kim J, Kim T, Petsko GA, Ritz J, Cohen BM, Kong SW, Leblanc P, Carter BS, Kim KS.
N Engl J Med. 2020 May 14;382(20):1926-1932. doi: 10.1056/NEJMoa1915872.
De Marco R, Bhargava D, Macerollo A, Osman-Farah J.
J Clin Neurosci. 2020 Jul;77:89-93. doi: 10.1016/j.jocn.2020.05.029. Epub 2020 May 10.
Bevilacqua R, Maranesi E, Di Rosa M, Luzi R, Casoni E, Rinaldi N, Baldoni R, Lattanzio F, Di Donna V, Pelliccioni G, Riccardi GR.
BMC Neurol. 2020 May 13;20(1):186. doi: 10.1186/s12883-020-01759-4.
Clinical trials in REM sleep behavioural disorder: challenges and opportunities
Videnovic A, Ju YS, Arnulf I, Cochen-De Cock V, Högl B, Kunz D, Provini F, Ratti PL, Schiess MC, Schenck CH, Trenkwalder C; Treatment and Trials Working Group of the International RBD Study Group.
J Neurol Neurosurg Psychiatry. 2020 Jul;91(7):740-749. doi: 10.1136/jnnp-2020-322875. Epub 2020 May 13.
Yao NT, Zheng Q, Xu ZQ, Yin JH, Lu LG, Zuo Q, Yang S, Zhang CL, Jiao L.
Chin Med J (Engl). 2020 Jun 20;133(12):1448-1455. doi: 10.1097/CM9.0000000000000836.
Epigenetic regulation in the pathophysiology of Lewy body dementia
Chouliaras L, Kumar GS, Thomas AJ, Lunnon K, Chinnery PF, O'Brien JT.
Prog Neurobiol. 2020 Sep;192:101822. doi: 10.1016/j.pneurobio.2020.101822. Epub 2020 May 12.
Generation and Release of Mitochondrial-Derived Vesicles in Health, Aging and Disease
Picca A, Guerra F, Calvani R, Coelho-Junior HJ, Bossola M, Landi F, Bernabei R, Bucci C, Marzetti E.
J Clin Med. 2020 May 12;9(5):1440. doi: 10.3390/jcm9051440.
Neurovascular Unit Dysfunction and Neurodegenerative Disorders
Yu X, Ji C, Shao A.
Front Neurosci. 2020 Apr 29;14:334. doi: 10.3389/fnins.2020.00334. eCollection 2020.
Multiple-Hit Hypothesis in Parkinson's Disease: LRRK2 and Inflammation
Cabezudo D, Baekelandt V, Lobbestael E.
Front Neurosci. 2020 Apr 28;14:376. doi: 10.3389/fnins.2020.00376. eCollection 2020.
Glucagon-like peptide-1 (GLP-1)-based receptor agonists as a treatment for Parkinson's disease
Glotfelty EJ, Olson L, Karlsson TE, Li Y, Greig NH.
Expert Opin Investig Drugs. 2020 Jun;29(6):595-602. doi: 10.1080/13543784.2020.1764534. Epub 2020 May 15.
Voruz P, Le Jeune F, Haegelen C, N'Diaye K, Houvenaghel JF, Sauleau P, Drapier S, Drapier D, Grandjean D, Vérin M, Péron J.
Neuropsychologia. 2020 Jul;144:107494. doi: 10.1016/j.neuropsychologia.2020.107494. Epub 2020 May 13.
Mayfield JJ, Goldschlager N.
J Electrocardiol. 2020 May-Jun;60:188-191. doi: 10.1016/j.jelectrocard.2020.04.025. Epub 2020 May 3.
Recommendations for Standards of Network Care for Patients with Parkinson's Disease in Germany
Prell T, Siebecker F, Lorrain M, Eggers C, Lorenzl S, Klucken J, Warnecke T, Buhmann C, Tönges L, Ehret R, Wellach I, Wolz M.
J Clin Med. 2020 May 13;9(5):1455. doi: 10.3390/jcm9051455.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.